30 Publications (Page 2 of 2)
2000
Intravenous diltiazem and CYP3A-mediated metabolism.Masica, A L⋅Azie, N E⋅Brater, D C⋅Hall, Stephen D and Jones, David RBritish journal of clinical pharmacology, vol. 50, (no. 3), pp. 273-6, 2000/Sep.
| Journal Article
In vivo effects of interleukin-10 on human cytochrome P450 activity.Gorski, J. C⋅Hall, Stephen D⋅Becker, P⋅Affrime, M B⋅Cutler, D L and Haehner-Daniels, BClinical pharmacology and therapeutics, vol. 67, (no. 1), pp. 32-43, 2000/Jan.
| Journal Article
1999
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.Gorski, J. C⋅Jones, David R⋅Hamman, M A⋅Wrighton, S A and Hall, Stephen DXenobiotica; the fate of foreign compounds in biological systems. , vol. 29, (no. 9), pp. 931-44, 1999/Sep.
| Journal Article
Molecular and physical mechanisms of first-pass extraction.Hall, Stephen D⋅Thummel, K E⋅Watkins, Paul⋅Lown, K S⋅Benet, Leslie Z⋅Paine, M F⋅Mayo, R R⋅Turgeon, D. K⋅Bailey, D G⋅Fontana, R J and Wrighton, S ADrug metabolism and disposition: the biological fate of chemicals. , vol. 27, (no. 2), pp. 161-6, 1999/Feb.
| Journal Article
1997
Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.Gorski, J. C⋅Jones, David R⋅Wrighton, S A and Hall, Stephen DXenobiotica; the fate of foreign compounds in biological systems, vol. 27, (no. 3), pp. 243-56, 1997/Mar.
| Journal Article